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Abstract
Acinar cell cystadenoma (ACA) of the pancreas has been newly recognized as an entity by the World Health
Organization (WHO) definition (2010), and its pathogenesis has not been known adequately because of the rarity.
Here, we report a case of a 22-year-old female who had been followed up for a cystic lesion at the tail of the
pancreas pointed out by a screening computed tomography (CT) scan 7 years ago. The tumor grew in size from 3.3
to 5.1 cm in diameter for 6 years (0.3 cm per year). Particularly, it rapidly grew up to 6.3 cm in the latest 3 months
in concurrence with the emergence of epigastralgia. A contrasted CT scan revealed the irregularly formed,
multilocular cystic tumor having thin septum and calcification. The intratumoral magnetic resonance imaging
intensity in the T1 and T2 weighted images were low and high, respectively. No communications between the
tumor and the main pancreatic duct (MPD) were found, but the tumor displaced the MPD. She underwent surgical
resection because the tumor was growing, turned symptomatic, and it seemed difficult to be diagnosed correctly
until totally biopsied. Spleen-preserved distal pancreatectomy was performed. It was pathologically diagnosed as
ACA; the cyst was lined by cells with normal acinar differentiation; cuboidal cells with round, basally oriented nuclei
and eosinophilic granules in its apical cytoplasm. The abdominal pain has disappeared, and no recurrences have
been found during a 5-year follow-up. Clinicians are recommended to consider an ACA as one of differential
diagnoses of cystic tumors of the pancreas to provide appropriate diagnostics and therapeutics.
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Background
Acinar cell neoplasms of the pancreas is a rare disease
representing only 2 % of pancreatic neoplasms [1]. Acinar
cystic transformation as a benign lesion, called an acinar
cell cystadenoma (ACA), is particularly rare to be diag-
nosed. ACAs are benign cystic lesions lined by cells with
acinar differentiation without atypical changes [2]. ACA
was first reported as an autopsied case in April 2002 by
Albores-Saavedra [3]. In the literature, 47 patients of
ACAs of pancreas were reported so far [1, 3–13]. To date,
the pathogenesis of ACAs remains unclear although it is
assumed that it could be mainly acinar metaplasia [2]. The
epidemiology and natural history of ACAs also remain un-
clear because of the insufficient number of reported cases.
Additionally, ACAs confers difficulty in imaging diagnosis
due to lack of distinctive features. Previous studies indi-
cated that ACAs may harbor some genetic alterations. We
herein reported a surgical case of ACA with bibliographic
considerations.
Case presentation
A 22-year-old female had been followed up annually at a
former hospital for a cystic mass at the tail of the pan-
creas, which had been pointed out by a screening com-
puted tomography (CT) scan to diagnose an acute
abdomen, such as peritonitis and ovarian torsion, when
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she was 15 years old (Fig. 1). After she has transferred to
our hospital, a routine follow-up has been provided to
put the lesion under surveillance. Six years after the first
diagnosis, she started to suffer from intermittent epigas-
tralgia and back pain usually at night, lasting for 2 to
3 h. The tumor grew in size from 3.3 to 5.1 cm in diam-
eter for 6 years (0.3 cm per year). Particularly, it rapidly
grew up to 6.3 cm in the last 3 months in concurrence
with the emergence of epigastralgia (Fig. 2). A CT scan
detected a solitary, irregularly formed, multilocular cystic
tumor with thin septum and calcification. Its septum
and capsule are not enhanced, and both splenic artery
and vein are not invaded by the tumor (Fig. 2). In find-
ings of magnetic resonance imaging (MRI), the tumor
showed low intensity in T1 and high intensity in a T2
weighted image (Fig. 3). Endoscopic ultrasound sonog-
raphy (EUS) identified a multilocular cystic lesion with
calcification, but no nodules on the septal walls were de-
tected. There were no communications between the cys-
tic tumor and the main pancreatic duct (MPD) or any
mucinous discharge from the papilla during endoscopic
retrograde pancreatography (ERP). The distal portion of
the MPD was clearly displaced by the tumor. Further-
more, small branches of the pancreatic duct around the
tumor were detected (Fig. 4). Neither pancreatic juice
cytology nor EUS-guided fine-needle aspiration were
performed. She had no familial history, past medical his-
tory, or allergic history. Physical examination did not re-
veal any tenderness or palpable mass at the abdomen.
The laboratory data before treatment was almost normal
including tumor markers for pancreatic tumors.
Mucinous cystic neoplasm (MCN), serous cystic neo-
plasm (SCN), and branch duct intraductal papillary mu-
cinous neoplasms (BD-IPMN) were considered as
differential diagnoses. According to IPMN/MCN guide-
lines [14], surgical resection might be recommended be-
cause of her age and size of the tumor, being
symptomatic and getting larger than before. Accordingly,
we decided to propose surgical resection, and written in-
formed consent was obtained.
Intraoperatively, we found a very soft and multilocular
cystic tumor having a thin capsule without adhesion or
invasion to the adjacent tissues. Because the tumor was
unlikely to be malignant, we performed a spleen-
preserved distal pancreatectomy without a systemic
lymph node dissection. Splenic artery and vein are also
preserved. The cut line was easily determined because
the tumor was well-demarcated macroscopically. Intra-
operative ultrasonography also showed no evidence of
mural nodules. We also ensured that the resection mar-
gins were cancer-free by examining intraoperative frozen
sections. The lesion is comprised of very soft and multi-
locular cysts containing serous fluid and focal calcifica-
tion (Fig. 5). The postoperative course was uneventful
and she discharged on the postoperative day nine. After
surgery, the abdominal pain has disappeared.
In pathological examinations, a cystic lesion lined by
cells with acinar differentiation was pointed out. The nu-
clei are uniform and basally oriented without atypical
changes (Fig. 6). In immunohistochemical staining, posi-
tive staining of α1-antichymotrypsin, α1-antitrypsin
(pancreatic enzyme marker), AE1/AE3, CAM-5.2 and
CK7 (epithelial marker), and MIB-1 index was <1 %.
Based on these pathological findings, it was finally diag-
nosed as an ACA (Fig. 7). Five years have passed after
resection, and no recurrences of the tumor and symp-
toms were seen.
Discussion
Here, we reported a surgical case of an ACA of the pan-
creas, which showed interesting radiologic features and
clinical courses. We have clarified the description of the
MPD image, based on the results of ERP.
Acinar cell neoplasms are recognized as a rare entity.
Particularly, ACAs, lined by cells with acinar differenti-
ation without atypical changes, are reported to be ex-
tremely rare [2]. The acinar cells play a role in
pancreatic exocrine. Although the acinar cells constitute
a large portion of the pancreatic parenchyma, most ma-
lignant cells were derived from other components, such
as ductal adenocarcinomas from the ductal cells and
neuroendocrine tumors from the beta cells [2].
ACA incidentally detected during autopsy was first re-
ported in April 2002 [3]. After that, several case reports
have been reported, and eventually, the definition of
ACA was established by the WHO classification of
Fig. 1 CT scan detected a low-dense and multilocular cystic tumor having thin septum and calcification. The tumor size is 3.3 cm in diameter
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tumors of the digestive system in 2010 [15]. As of
September 2015, 12 papers including 48 patients were
identified in the literature search by the PubMed data-
base (http://www.ncbi.nlm.nih.gov/pubmed) [1, 3–13].
All of them were diagnosed by the pathological findings
of surgical or autopsied specimens.
In the literature review, females are predominant (30
of 48 cases, 64 %). Approximately two thirds of the
patients had complains of an abdominal pain or discom-
fort. Postoperative follow-up period was widely ranged
from 5 months to 11 years. There has not been any case
reported on recurrence or evident malignant transform-
ation so far. Whether ACAs is a congenital disease is
dismissive so far because the age of the patients widely
ranged 9–71 years old (mean 42.9 years). The most typ-
ical radiological appearances of ACAs are reported to be
Fig. 3 Magnetic resonance imaging revealed the mass low intensity in the T1-weighted image (a) and high intensity in the T2-weighted
image (b)
Fig. 2 Enhanced CT scan showed that the tumor size increased to 5.1 cm in diameter for 6 years (a) and in the subsequent 3 months increased
to 6.3 cm eventually (b). Its septum and capsule are not enhanced, and both splenic artery (black arrow head) and splenic vein (white arrow head)
are not invaded by the tumor (c)
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homogeneous hypovascular cystic tumors with thin
septum. They show hypodensity in CT images, low in-
tensity on the T1-weighted MRI, and high intensity on
the T2-weighted MRI [13]. Usually, there are no com-
munications between the cysts and the MPD.
However, it is hard to distinguish from other cystic tu-
mors of the pancreas exclusively by imaging only be-
cause ACAs have less definitive morphologic features.
The size of ACAs was reported to have a wide range
from small incidentaloma to large tumor-suspected ma-
lignancy. Moreover, some ACAs diffusely involved entire
pancreatic grand or increased in diameter during long-
term follow-up. The most frequent site of ACAs was re-
ported to be the head of the pancreas (around half of
cases). Most of ACAs were solitary but some (approxi-
mately 10 %) of them have diffuse disease. The preva-
lence of unilocular or multilocular forms was equivalent.
Less than 10 % of ACAs showed a communication to
the MPD like BD-IPMNs. Eight cases of them are
Fig. 5 Macroscopic image of raw specimen (a) and fixated and cut specimen (b). The lesion is comprised of very soft and multilocular cysts with
focal calcification (arrow). The cut margin is indicated by an arrow head
Fig. 4 Endoscopic retrograde pancreatography showed that the
distal portion of the main pancreatic duct is not stenosed but
displaced by the tumor (white arrow head), and its branches are also
clearly described (black arrow head)
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reported to have calcifications inside the tumor, and it is
known to be a similar finding as SCNs. Some of them
have thick capsules, which is frequently seen in MCNs.
In the literature, pre-operative diagnoses are IPMN
(eight cases), MCN (three cases), SCN (one case), and
neuroendocrine tumor (one case), etc.
Although even EUS-guided fine-needle aspiration was
performed in 21 cases, none of them were diagnosed as
ACAs because of its hypocellularity [7]. Accordingly, it
would be challenging to distinguish ACAs from other
pancreatic cystic tumors by a pre-operative imaging. A
review of the literature showed that 37 patients were di-
agnosed following surgical resection, including two pa-
tients who underwent incomplete resection and four
who were found to have ACA incidentally [4]. One pa-
tient was diagnosed by surgical biopsy [1, 8].
ERP of the presented case clearly described that an
image of MPD which is not connected to any cyst or
without stenosis differs from images common to IPMN
and other malignant tumors. Furthermore, small
branches of the pancreatic duct were detected,
suggesting that the tumor was soft and plastic. Surgical
findings were also in agreement, providing further evi-
dence for acinar metaplasia. Relative to MRP, which
most previous reports presented, ERP can provide more
precise information on the pancreatic duct without
interference by cystic lesions. These finding may be use-
ful in distinguishing ACAs from other cystic neoplasms,
although it is not definitive.
Histologically, the surface of the cystic walls con-
sists of one or several cell layers with normal acinar
cells; cuboidal cells with round, basally oriented nu-
clei and eosinophilic, periodic acid stain (PAS)-posi-
tive granules in its apical cytoplasm. Mitoses are
rarely observed [2, 4, 11]. In terms of immunohisto-
chemistry, the staining patterns are identical to those
of normal acinar cells of the pancreas, expressing
pancreatic enzymes, positive at chymotrypsin, trypsin,
lipase, and epithelial markers such as AE1/AE3 and
CAM-5.2. The expression of CK7 was reported to be
an identifiable difference from non-neoplastic acinar
cells [4, 7, 10]. Usually, MIB-1 index is <1 % [4].
Fig. 6 Image of microscopic specimen. Low magnified findings (a); the lesion is comprised of large and small cysts. High magnified findings (b);
cystic lesion is lined by cells with acinar differentiation which have eosinophilic granules in their apical cytoplasms. The nuclei are uniform, lack
atypia, and basally oriented
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The pathogenesis of ACAs remains unclear. Now, it is
assumed that acinar metaplasia could be the main patho-
genesis of ACAs based on results of the immunohisto-
chemistry [2]. However, Khor et al. have suggested that
ACAs are neoplastic because of the augmentation in copy
number of specific genes, which array comparative gen-
omic hybridization provides in an ACA with mural nod-
ules [7]. In contrast, the polyclonality of the X
chromosome suggested that ACAs are benign non-
neoplastic ballooning of the acinar epithelium [10]. Con-
cerning malignant potential or transformation of ACAs to
acinar cell carcinoma, there also is insufficient evidence to
determine factors associated with it [4]. Although the
WHO classification also does not describe a relationship
between ACAs and acinar cell carcinoma [15], this rela-
tionship has not yet been determined because ACAs are
newly recognized entities and ACAs, acinar cell carcin-
omas, and acinar cystadenocarcinomas are very rare.
At present, although ACAs are finally diagnosed by
pathological examination of surgical specimen, we would
like to propose two approaches when you encounter cystic
lesions. First, the diagnostic clues of ACAs can be proposed
from our experience and the literatures as follows: younger
females, round-shaped cystic tumor without evidence of
the MPD stricture, no communications to the MPD (unlike
IPMN), thin capsules (unlike MCN), and non-honeycomb
type (unlike SCN). Second, modification of the general ap-
proach may be preferable when the ACAs are included in
the differential diagnosis of the cystic mass. Occasionally,
total pancreatectomy or pancreatoduodenectomy are re-
quired for resection when the lesions, suspected of being
malignant, are multiple, diffuse, or located in the pancreatic
head. In such situations, surgical biopsy, which is not in-
cluded in the guidelines for the management of IPMN and
MCN [14], can be an option of diagnosing strategy.
Conclusions
Here, we reported a rare surgical case of ACA following
a long-term surveillance. It showed interesting radiologic
features and clinical courses. Clinicians are recom-
mended to consider an ACA as one of differential diag-
noses of cystic tumors of the pancreas to provide an
appropriate treatment.
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Fig. 7 Immunohistochemical staining. Positive staining of α1-antichymotrypsin (a), α1-antitrypsin (b), AE1/AE3 (c), CAM-5.2 (d), and CK7 (e) were
seen. The MIB-1 index is <1 % (f)
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